Production (Stage)
NLS Pharmaceutics AG
NLSP
$2.30
$0.2210.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 85.52% | 85.52% | -66.53% | -66.53% | -89.97% |
| Total Receivables | 1,180.63% | 1,180.63% | 25.97% | 25.97% | -14.81% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -34.20% | -34.20% | -39.52% | -39.52% | -63.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -92.06% | -92.06% | 591.53% | 591.53% | 1,150.08% |
| Total Current Assets | 22.08% | 22.08% | -46.89% | -46.89% | -80.28% |
|
|
|||||
| Total Current Assets | 22.08% | 22.08% | -46.89% | -46.89% | -80.28% |
| Net Property, Plant & Equipment | 8.96% | 8.96% | -91.94% | -91.94% | -62.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -98.22% | -98.22% | -- | -- | 39.67% |
| Total Assets | 20.93% | 20.93% | -47.43% | -47.43% | -80.09% |
|
|
|||||
| Total Accounts Payable | -88.87% | -88.87% | 47.26% | 47.26% | 95.23% |
| Total Accrued Expenses | -79.78% | -79.78% | 82.24% | 82.24% | 58.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 766.15% |
| Total Other Current Liabilities | -- | -- | -- | -- | 766.15% |
| Total Current Liabilities | -89.56% | -89.56% | 98.29% | 98.29% | 135.72% |
|
|
|||||
| Total Current Liabilities | -89.56% | -89.56% | 98.29% | 98.29% | 135.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 2.96% | 2.96% | 4.73% |
| Total Liabilities | -92.26% | -92.26% | 59.55% | 59.55% | 78.13% |
|
|
|||||
| Common Stock & APIC | 18.30% | 18.30% | 2.40% | 2.40% | 0.27% |
| Retained Earnings | -5.76% | -5.76% | -10.02% | -10.02% | -20.91% |
| Treasury Stock & Other | 168.88% | 168.88% | 103.20% | 103.20% | -211.22% |
| Total Common Equity | 84.89% | 84.89% | -116.21% | -116.21% | -369.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 84.89% | 84.89% | -116.21% | -116.21% | -369.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 115.92% | 115.92% | -116.21% | -116.21% | -369.25% |
|
|
|||||